{"id":"https://openalex.org/W2019540147","doi":"https://doi.org/10.1021/mp8002495","title":"Mechanistic Modeling of Hepatic Transport from Cells to Whole Body: Application to Napsagatran and Fexofenadine","display_name":"Mechanistic Modeling of Hepatic Transport from Cells to Whole Body: Application to Napsagatran and Fexofenadine","alternate_titles":[],"publication_year":2009,"publication_date":"2009-09-09","ids":{"openalex":"https://openalex.org/W2019540147","doi":"https://doi.org/10.1021/mp8002495","mag":"2019540147","pmid":"https://pubmed.ncbi.nlm.nih.gov/19739673"},"language":"en","primary_location":{"id":"doi:10.1021/mp8002495","doi":"https://doi.org/10.1021/mp8002495","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp8002495","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2019540147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001415334","display_name":"Agn\u00e8s Poirier","orcid":"https://orcid.org/0000-0002-7077-009X","observed_orcids":["https://orcid.org/0000-0002-7077-009X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210107416","display_name":"Roche (France)","ror":"https://ror.org/01mqmer16","country_code":"FR","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210107416"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["CH","FR"],"is_corresponding":true,"raw_author_name":"Agn\u00e8s Poirier","raw_affiliation_strings":["Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I154526488","https://openalex.org/I4210107416","https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001393185","display_name":"Christoph Funk","orcid":"https://orcid.org/0000-0001-7388-4415","observed_orcids":["https://orcid.org/0000-0001-7388-4415"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210107416","display_name":"Roche (France)","ror":"https://ror.org/01mqmer16","country_code":"FR","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210107416"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["CH","FR"],"is_corresponding":false,"raw_author_name":"Christoph Funk","raw_affiliation_strings":["Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I154526488","https://openalex.org/I4210107416","https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108778722","display_name":"Jean\u2010Michel Scherrmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210107416","display_name":"Roche (France)","ror":"https://ror.org/01mqmer16","country_code":"FR","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210107416"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["CH","FR"],"is_corresponding":false,"raw_author_name":"Jean-Michel Scherrmann","raw_affiliation_strings":["Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I154526488","https://openalex.org/I4210107416","https://openalex.org/I4387156284"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044090708","display_name":"Thierry Lav\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210107416","display_name":"Roche (France)","ror":"https://ror.org/01mqmer16","country_code":"FR","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210107416"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["CH","FR"],"is_corresponding":false,"raw_author_name":"Thierry Lav\u00e9","raw_affiliation_strings":["Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety, Non-Clinical Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland, and Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, INSERM U705, Paris, France","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I154526488","https://openalex.org/I4210107416","https://openalex.org/I4387156284"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5001415334"],"corresponding_institution_ids":["https://openalex.org/I118019719","https://openalex.org/I154526488","https://openalex.org/I4210107416","https://openalex.org/I4387156284"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.3465,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.94760733,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"6","issue":"6","first_page":"1716","last_page":"1733"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.022700000554323196,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fexofenadine","display_name":"fexofenadine","score":1.0},{"id":"https://openalex.org/keywords/passive-diffusion","display_name":"passive diffusion","score":0.6919999718666077},{"id":"https://openalex.org/keywords/biliary-excretion","display_name":"biliary excretion","score":0.7960000038146973},{"id":"https://openalex.org/keywords/michaelis-menten-kinetics","display_name":"Michaelis-Menten kinetics","score":0.8429999947547913},{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-model","display_name":"physiologically based pharmacokinetic modeling","score":0.7739999890327454},{"id":"https://openalex.org/keywords/hepatocyte-uptake","display_name":"hepatocyte uptake","score":0.48399999737739563},{"id":"https://openalex.org/keywords/nonspecific-binding","display_name":"non-specific binding","score":0.6290000081062317},{"id":"https://openalex.org/keywords/uncertainty-analysis","display_name":"uncertainty analysis","score":0.5640000104904175},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C2776711289","wikidata":"https://www.wikidata.org/wiki/Q415122","display_name":"Fexofenadine","level":2,"score":0.9284761548042297},{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.559149444103241},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5408819317817688},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5099245309829712},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21523120999336243}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/mp8002495","doi":"https://doi.org/10.1021/mp8002495","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp8002495","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:19739673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19739673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W181926110","https://openalex.org/W1502459074","https://openalex.org/W1573855997","https://openalex.org/W1860688311","https://openalex.org/W1894069565","https://openalex.org/W1937894166","https://openalex.org/W1968857994","https://openalex.org/W1986513453","https://openalex.org/W1987044402","https://openalex.org/W1991031764","https://openalex.org/W1994206407","https://openalex.org/W2005101461","https://openalex.org/W2009570004","https://openalex.org/W2009858196","https://openalex.org/W2013322396","https://openalex.org/W2019306159","https://openalex.org/W2027413685","https://openalex.org/W2028523934","https://openalex.org/W2036316801","https://openalex.org/W2039250788","https://openalex.org/W2039539582","https://openalex.org/W2042506106","https://openalex.org/W2044814462","https://openalex.org/W2057955349","https://openalex.org/W2060992818","https://openalex.org/W2063332525","https://openalex.org/W2064413682","https://openalex.org/W2064799851","https://openalex.org/W2066382275","https://openalex.org/W2067254007","https://openalex.org/W2072784247","https://openalex.org/W2072981607","https://openalex.org/W2075926689","https://openalex.org/W2080269820","https://openalex.org/W2081536956","https://openalex.org/W2081656085","https://openalex.org/W2085335377","https://openalex.org/W2087019364","https://openalex.org/W2087759076","https://openalex.org/W2097961663","https://openalex.org/W2113830209","https://openalex.org/W2116796907","https://openalex.org/W2121102751","https://openalex.org/W2125748363","https://openalex.org/W2133257763","https://openalex.org/W2133677036","https://openalex.org/W2134213562","https://openalex.org/W2145481170","https://openalex.org/W2146393360","https://openalex.org/W2148090699","https://openalex.org/W2150060563","https://openalex.org/W2151060548","https://openalex.org/W2151696031","https://openalex.org/W2152796502","https://openalex.org/W2156445661","https://openalex.org/W2157619122","https://openalex.org/W2158240950","https://openalex.org/W2160350843","https://openalex.org/W2165334931","https://openalex.org/W2170958988","https://openalex.org/W2171167058","https://openalex.org/W2171654601","https://openalex.org/W2171671443","https://openalex.org/W2421822530","https://openalex.org/W2525183727"],"related_works":["https://openalex.org/W1972328515","https://openalex.org/W2090298231","https://openalex.org/W1975908811","https://openalex.org/W2070411337","https://openalex.org/W2162138804","https://openalex.org/W2127379750","https://openalex.org/W2030871745","https://openalex.org/W2330652774","https://openalex.org/W2120152745"],"abstract_inverted_index":{"A":[0],"mechanistic":[1,32,79,395],"model":[2,49,80,150,396],"was":[3,67,81,130,156,170,211,245,253,269,275],"applied":[4],"to":[5,24,83,114,172,236,255,262,290,316,327],"quantitatively":[6],"derive":[7,84],"the":[8,85,153,159,168,173,177,195,237,249,259,309,329,369,394,406,415],"kinetic":[9,299,408],"parameters":[10,19,94,117,138,409],"from":[11,132],"in":[12,26,69,115,133,144,151,176,192,265,296,311,354,402,418],"vitro":[13,193,297,312,362,403],"hepatic":[14,182,278,411],"uptake":[15,93,238,313,363,412],"transport":[16,89,107,137,164,197,298,413],"data.":[17],"These":[18,136],"were":[20,46,112,139,190,288,357],"used":[21,82,141],"as":[22,48,142],"input":[23,143],"simulate":[25],"vivo":[27,116,134,419],"elimination":[28],"using":[29,121,425],"a":[30,78,145],"fully":[31],"physiologically":[33,148],"based":[34,72,149,293],"pharmacokinetic":[35],"(PBPK)":[36],"model.":[37],"Fexofenadine":[38,210],"and":[39,58,77,87,96,103,109,119,127,162,187,230,283,331,334,344,351,372,405,422],"napsagatran,":[40],"both":[41,53,307],"BDDCS":[42],"class":[43],"3":[44],"drugs,":[45],"chosen":[47],"compounds.":[50],"In":[51,361],"rat,":[52],"compounds":[54,308],"are":[55,59],"hardly":[56],"metabolized":[57],"eliminated":[60],"unchanged":[61],"mostly":[62],"through":[63,125],"biliary":[64,250,335,373,387],"excretion.":[65],"Uptake":[66],"estimated":[68],"this":[70,339],"study":[71,391],"on":[73,294,368],"plated":[74],"rat":[75,216],"hepatocytes,":[76],"active":[86,128,163,196],"passive":[88,100,110,126,161,185,234],"parameters,":[90],"namely":[91],"Michaelis-Menten":[92],"(V(maxI)":[95],"K(mI,u))":[97],"together":[98],"with":[99,319],"diffusion":[101,111,186,235],"(P(dif))":[102],"nonspecific":[104],"binding.":[105],"Maximum":[106],"velocity":[108],"scaled":[113,295,310,407],"(J(maxI)":[118],"PS(TC))":[120],"hepatocellularity.":[122],"Biliary":[123],"excretion,":[124],"transport,":[129],"assessed":[131],"studies.":[135],"then":[140],"whole":[146],"body":[147],"which":[152],"liver":[154,282,332,348,380],"compartment":[155],"parametrized":[157],"for":[158,271,306,398],"different":[160],"processes.":[165],"Each":[166],"of":[167,233,325,379,386,401,410,417],"processes":[169],"linked":[171],"free":[174],"concentration":[175,285,349],"relevant":[178],"compartment.":[179],"For":[180,247],"napsagatran":[181,272],"uptake,":[183,260],"no":[184,188],"binding":[189],"detected":[191],"besides":[194],"(K(mI,u)":[198,218],"=":[199,205,219,225,240],"88.4":[200],"+/-":[201,207,221,227,242],"8.1":[202],"microM,":[203,223],"V(maxI)":[204,224],"384":[206],"19":[208],"pmol/mg/min).":[209],"rapidly":[212],"taken":[213],"up":[214],"into":[215],"hepatocytes":[217],"271":[220],"35":[222],"3162":[226],"274":[228],"pmol/mg/min),":[229],"some":[231],"contribution":[232],"(P(dif)":[239],"2.08":[241],"0.67":[243],"microL/mg/min)":[244],"observed.":[246],"fexofenadine,":[248],"export":[251],"rate":[252],"found":[254],"be":[256,317],"slower":[257],"than":[258,277],"leading":[261],"drug":[263],"accumulation":[264,268],"liver.":[266],"No":[267],"observed":[270],"where":[273],"excretion":[274,336,374,388],"faster":[276],"uptake.":[279],"Observed":[280],"plasma,":[281],"bile":[284,355],"time":[286],"profiles":[287,421],"compared":[289],"PBPK":[291,426],"simulations":[292,378],"parameters.":[300],"An":[301],"uncertainty":[302],"analysis":[303],"indicated":[304,392],"that":[305,393],"clearance":[314,342],"had":[315,365],"adjusted":[318],"an":[320],"additional":[321],"empirical":[322],"scaling":[323],"factor":[324],"10":[326],"match":[328],"plasma":[330,341,371,423],"concentrations":[333,381],"profiles.":[337],"Applying":[338],"model,":[340],"(CL(P))":[343],"half-life":[345],"(t(1/2)),":[346],"maximum":[347],"(C(maxL))":[350],"fraction":[352],"excreted":[353],"(f(bile))":[356],"predicted":[358],"within":[359],"2-fold.":[360],"data":[364],"most":[366],"impact":[367],"simulated":[370],"profiles,":[375],"while":[376],"accurate":[377,399],"required":[382],"also":[383],"quantitative":[384],"estimates":[385],"transport.":[389],"This":[390],"allowed":[397],"evaluation":[400],"experiments;":[404],"enabled":[414],"prediction":[416],"PK":[420],"clearances,":[424],"modeling.":[427]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2019540147","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
